Author Correction: Acquired hypophosphatemic osteomalacia: case series from a Peruvian referral center (1999–2023) (Archives of Osteoporosis, (2024), 19, 1, (116), 10.1007/s11657-024-01476-2)
- José Paz-Ibarra,
- Sofía Sáenz-Bustamante,
- Manuel Inostroza-Fernández,
- Paola Sifuentes Hermenegildo,
- Liliana Ancajima Lescano,
- Hospital Nacional Edgardo Rebagliati Martins, EsSalud,
- Universidad Nacional Mayor de San Marcos,
- Instituto Nacional de Ciencias Médicas y Nutrición,
- Hospital María Auxiliadora,
- Centro Geriátrico Naval del Perú,
Open access
Publication Information
Output type
Original language
EnglishArticle number
92Journal (Volume, Issue Number)
Archives of Osteoporosis (Volume 20, Issue 1)Publication milestones
- Published - 12/2025
Publication status
ISSN
1862-3522Publication IDs
- Scopus: 105010839851
Abstract
The original online version of this article was revised: In the original publication of this article, an error was identified in the first paragraph of the Discussion section. The original sentence read: “Among the causes of FGF-23-dependent acquired hypophosphatemic osteomalacia (AHO) are TIO, and other exogenous causes are intravenous iron preparations such as iron polymaltose and ferric carboxymaltose, some drugs that cause Fanconi syndrome, and alcohol consumption [2, 3].” “Among the causes of FGF-23-dependent acquired hypophosphatemic osteomalacia (AHO) are TIO, and other exogenous causes are intravenous iron preparations such as iron polymaltose and ferric carboxymaltose, some drugs that cause Fanconi syndrome, and alcohol consumption [2, 3].” Correction: The clause “some drugs that cause Fanconi syndrome,” has been removed because Fanconi syndrome induces hypophosphatemia through mechanisms not dependent on FGF-23, and its inclusion in this context was incorrect. The corrected sentence should read: “Among the causes of FGF-23-dependent acquired hypophosphatemic osteomalacia (AHO) are TIO, and other exogenous causes are intravenous iron preparations such as iron polymaltose and ferric carboxymaltose, and alcohol consumption [2, 3].” “Among the causes of FGF-23-dependent acquired hypophosphatemic osteomalacia (AHO) are TIO, and other exogenous causes are intravenous iron preparations such as iron polymaltose and ferric carboxymaltose, and alcohol consumption [2, 3].” Additionally, for clarification, the following explanatory sentence may be added: “Fanconi syndrome caused by some drugs can also cause hypophosphatemia, but by mechanisms not dependent on FGF-23.” “Fanconi syndrome caused by some drugs can also cause hypophosphatemia, but by mechanisms not dependent on FGF-23.” The authors regret this oversight and thank Professor Seiji Fukumoto for his valuable observation. The original article has been corrected.
